US government exercises $144m option for smallpox/mpox vaccine contract
The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.
Recursion is streamlining its portfolio in the wake of its 2024 merger with Exscientia.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
3 reasons why biotechs preparing for launch need a compliant content foundation
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery